about
Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion.Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.The autophagy machinery restrains iNKT cell activation through CD1D1 internalization.ATGs help MHC class II, but inhibit MHC class I antigen presentationMacroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses.Endocytosis regulation by autophagy proteins in MHC restricted antigen presentationMHC Class I Internalization via Autophagy ProteinsLC3-Associated Phagocytosis and Antigen Presentation
P50
Q35049970-5C4FAB53-A7C0-4C57-B179-37945C3C8EE8Q38128317-2C2F803F-3617-4197-AAFA-8ADFB54F42D2Q38805799-BAAC0D51-7647-4C5F-8CDE-DDA790F7592FQ38843502-69B226CD-E437-48A3-89C2-BCC3777AA80AQ38868828-E5BA3E28-9433-4DF1-A865-7D4F6A96B05EQ38973832-BFCAB8BE-A495-4C66-9E2D-7E7045CE39A5Q40291259-00CFCBFE-D38B-4588-A273-B51D28D608F7Q40605931-677BA8AF-13C7-44E9-B17C-6A4B4FDF35CAQ40698021-8851520B-D97B-4442-B04C-4F7488747053Q88544288-0618C820-817A-4D0C-B604-E9C61F849B67Q90898461-847B35E2-55A5-48B2-98F3-B74480C68261Q91727126-726A938A-8761-45D7-82D6-B1A29D3BB01E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Monica Loi
@en
Monica Loi
@nl
type
label
Monica Loi
@en
Monica Loi
@nl
prefLabel
Monica Loi
@en
Monica Loi
@nl
P31
P496
0000-0001-8179-8445